BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 26692171)

  • 21. Clinical phenotypes of Cerebral Amyloid Angiopathy.
    Maia LF; Mackenzie IR; Feldman HH
    J Neurol Sci; 2007 Jun; 257(1-2):23-30. PubMed ID: 17341423
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Current concepts in vascular dementia].
    Benisty S
    Geriatr Psychol Neuropsychiatr Vieil; 2013 Jun; 11(2):171-80. PubMed ID: 23803634
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Arterial stiffness, cognitive impairment and dementia: confounding factor or real risk?
    Iulita MF; Noriega de la Colina A; Girouard H
    J Neurochem; 2018 Mar; 144(5):527-548. PubMed ID: 28991365
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Post-Stroke Cognitive Impairment and Dementia.
    Rost NS; Brodtmann A; Pase MP; van Veluw SJ; Biffi A; Duering M; Hinman JD; Dichgans M
    Circ Res; 2022 Apr; 130(8):1252-1271. PubMed ID: 35420911
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Progression in Vascular Cognitive Impairment: Pathogenesis, Neuroimaging Evaluation, and Treatment.
    Zhang X; Su J; Gao C; Ni W; Gao X; Li Y; Zhang J; Lei Y; Gu Y
    Cell Transplant; 2019 Jan; 28(1):18-25. PubMed ID: 30488737
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of spontaneous intracerebral hemorrhage on cognitive functioning: An update.
    Planton M; Raposo N; Danet L; Albucher JF; Péran P; Pariente J
    Rev Neurol (Paris); 2017; 173(7-8):481-489. PubMed ID: 28838790
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Science of Vascular Contributions to Cognitive Impairment and Dementia (VCID): A Framework for Advancing Research Priorities in the Cerebrovascular Biology of Cognitive Decline.
    Corriveau RA; Bosetti F; Emr M; Gladman JT; Koenig JI; Moy CS; Pahigiannis K; Waddy SP; Koroshetz W
    Cell Mol Neurobiol; 2016 Mar; 36(2):281-8. PubMed ID: 27095366
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mild cognitive impairment in stroke patients with ischemic cerebral small-vessel disease: a forerunner of vascular dementia?
    Grau-Olivares M; Arboix A
    Expert Rev Neurother; 2009 Aug; 9(8):1201-17. PubMed ID: 19673608
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neurovascular dysfunction and neurodegeneration in dementia and Alzheimer's disease.
    Nelson AR; Sweeney MD; Sagare AP; Zlokovic BV
    Biochim Biophys Acta; 2016 May; 1862(5):887-900. PubMed ID: 26705676
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cerebrovascular contributions to aging and Alzheimer's disease in Down syndrome.
    Wilcock DM; Schmitt FA; Head E
    Biochim Biophys Acta; 2016 May; 1862(5):909-14. PubMed ID: 26593849
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vascular contributions to cognitive impairment and dementia (VCID).
    Murphy MP; Corriveau RA; Wilcock DM
    Biochim Biophys Acta; 2016 May; 1862(5):857-9. PubMed ID: 26921818
    [No Abstract]   [Full Text] [Related]  

  • 32. Role of age-related alterations of the cerebral venous circulation in the pathogenesis of vascular cognitive impairment.
    Fulop GA; Tarantini S; Yabluchanskiy A; Molnar A; Prodan CI; Kiss T; Csipo T; Lipecz A; Balasubramanian P; Farkas E; Toth P; Sorond F; Csiszar A; Ungvari Z
    Am J Physiol Heart Circ Physiol; 2019 May; 316(5):H1124-H1140. PubMed ID: 30848677
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The many faces of vascular cognitive impairment.
    Girouard H; Munter LM
    J Neurochem; 2018 Mar; 144(5):509-512. PubMed ID: 29430652
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Regional amyloid burden and lacune in pure subcortical vascular cognitive impairment.
    Hong YJ; Kim CM; Kim JE; Roh JH; Kim JS; Seo SW; Na DL; Lee JH
    Neurobiol Aging; 2017 Jul; 55():20-26. PubMed ID: 28395177
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vascular mTOR-dependent mechanisms linking the control of aging to Alzheimer's disease.
    Galvan V; Hart MJ
    Biochim Biophys Acta; 2016 May; 1862(5):992-1007. PubMed ID: 26639036
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Progression of mild cognitive impairment to dementia: contribution of cerebrovascular disease compared with medial temporal lobe atrophy.
    Staekenborg SS; Koedam EL; Henneman WJ; Stokman P; Barkhof F; Scheltens P; van der Flier WM
    Stroke; 2009 Apr; 40(4):1269-74. PubMed ID: 19228848
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Time-course of glial changes in the hyperhomocysteinemia model of vascular cognitive impairment and dementia (VCID).
    Sudduth TL; Weekman EM; Price BR; Gooch JL; Woolums A; Norris CM; Wilcock DM
    Neuroscience; 2017 Jan; 341():42-51. PubMed ID: 27890830
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cerebral microbleed detection and mapping: principles, methodological aspects and rationale in vascular dementia.
    Charidimou A; Jäger HR; Werring DJ
    Exp Gerontol; 2012 Nov; 47(11):843-52. PubMed ID: 22750456
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of exercise in mitigating subcortical ischemic vascular cognitive impairment.
    Dao E; Hsiung GR; Liu-Ambrose T
    J Neurochem; 2018 Mar; 144(5):582-594. PubMed ID: 28833160
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Executive dysfunction and blockage of brain microvessels in a rat model of vascular cognitive impairment.
    Langdon KD; Cordova CA; Granter-Button S; Boyd JD; Peeling J; Murphy TH; Corbett D
    J Cereb Blood Flow Metab; 2018 Oct; 38(10):1727-1740. PubMed ID: 29083274
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.